NCI-sponsored phase II study of [18f]fluoroestradiol (FES) as a marker of hormone sensitivity of metastatic breast cancer: Initial results

被引:2
作者
Mankoff, D. A.
Linden, H. M.
Link, J.
Kurland, B. F.
Schubert, E. K.
Peterson, L.
Gadi, V. K.
Specht, J. M.
Shankar, L.
Eary, J. F.
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA
[4] NCI, Canc Imaging Program, Rockville, MD USA
关键词
D O I
10.1200/jco.2011.29.15_suppl.e11104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e11104
引用
收藏
页数:1
相关论文
empty
未找到相关数据